Valeant Pharmaceuticals International Reports Preliminary 2006 Third Quarter Financial Information

COSTA MESA, Calif.--(BUSINESS WIRE)--Valeant Pharmaceuticals International (NYSE:VRX) today announced preliminary financial information for the 2006 third quarter. Due to the ongoing review of the company’s stock option practices being conducted by a special committee of independent directors, the financial information announced today is preliminary and is likely to change. The preliminary financial information could be significantly impacted by the effects of the pending restatement associated with the stock option review and by information that may subsequently become available that could alter the estimates and assumptions used in its preparation. The company is providing the preliminary financial information contained in this release in order to provide, to the extent possible, an update on the company’s business; however, this should not be viewed as final. Final results will be reported once the special committee has completed its review and concluded that the impact of the restatement and all related reviews has been completed.

MORE ON THIS TOPIC